martinshkreli
Cop Your XXL Merch Now Martin Shkreli is being sued by the company that owns the one-of-a-kind Wu-Tang Clan album Once Upon a Time in Shaolin for copying and playing the album without prior permission. “Pharma Bro” Martin Shkreli Faces New LawsuitOn Monday (June 10), digital art collective PleasrDAO filed a lawsuit against “Pharma Bro” Martin Shkreli in New York Eastern District Court, according to court documents obtained by XXL on Wednesday (June 12).Shkreli purchased the 1-of-1 album for $2 million in 2015. PleasrDAO bought the album for $4,750,000 in 2024, according to the suit. However, t...
PopCrush
Cop Your XXL Merch Now Martin Shkreli is being sued by the company that owns the one-of-a-kind Wu-Tang Clan album Once Upon a Time in Shaolin for copying and playing the album without prior permission. “Pharma Bro” Martin Shkreli Faces New LawsuitOn Monday (June 10), digital art collective PleasrDAO filed a lawsuit against “Pharma Bro” Martin Shkreli in New York Eastern District Court, according to court documents obtained by XXL on Wednesday (June 12).Shkreli purchased the 1-of-1 album for $2 million in 2015. PleasrDAO bought the album for $4,750,000 in 2024, according to the suit. However, t...
XXL Mag
A law firm that has been representing the infamous “Pharma Bro” Martin Shkreli has asked a judge for permission to withdraw from his team after claiming he has skipped out on paying them. The firm, Duane Morris LLP is accusing Shkreli’s former company Phoenixus of initially agreeing to pay off his fees but has since fallen off on the payments after they no longer were covered by insurance. The firm alleges they are owed $2.04 million for legal services from October to March 31st. Duane Morris also added in their court filing that Shkreli “has no assets” to pay off these fees and that he didn’t...
uInterview.com
Former crime reporter for Bloomberg News, Christie Symthe, went public with her relationship with Martin Shkreli, also known as “Pharma Bro” after the biotech entrepreneur infamously raised a life-saving drug’s price up 5,000 percent. In a profile in Elle magazine, published Sunday, Smythe revealed that it all began when at Shkreli’s 2017 court hearing, where he was found guilty of misleading investors over a pair of hedge funds he operated. Smythe sat in on the trial, reporting for Bloomberg. “I fell down the rabbit hole,”she said. “I’m happy here. I feel like a have a purpose.” After Smythe ...
uInterview.com
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら